NZ735783A - Antifungal 4-(4-(4-(((3r,5r)-5-((1 h -1,2,4-triazol-1 -yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)- 3-methylphenyl)piperazin-1 -yl )-n -(2-h yd roxycyc lo h exyl) b e nzam i d e, or a pharmaceutically acceptable salt thereof. - Google Patents
Antifungal 4-(4-(4-(((3r,5r)-5-((1 h -1,2,4-triazol-1 -yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)- 3-methylphenyl)piperazin-1 -yl )-n -(2-h yd roxycyc lo h exyl) b e nzam i d e, or a pharmaceutically acceptable salt thereof.Info
- Publication number
- NZ735783A NZ735783A NZ735783A NZ73578316A NZ735783A NZ 735783 A NZ735783 A NZ 735783A NZ 735783 A NZ735783 A NZ 735783A NZ 73578316 A NZ73578316 A NZ 73578316A NZ 735783 A NZ735783 A NZ 735783A
- Authority
- NZ
- New Zealand
- Prior art keywords
- roxycyc
- nzam
- exyl
- piperazin
- difluorophenyl
- Prior art date
Links
- 230000000843 anti-fungal effect Effects 0.000 title 1
- 229940121375 antifungal agent Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15168637 | 2015-05-21 | ||
| PCT/GB2016/051467 WO2016185225A1 (en) | 2015-05-21 | 2016-05-20 | Antifungal 4-(4-(4-(((3r,5r)-5-((1 h -1,2,4-triazol-1 -yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)- 3-methylphenyl)piperazin-1 -yl )-n -(2-h yd roxycyc lo h exyl) b e nzam i d e, or a pharmaceutically acceptable salt thereof. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ735783A true NZ735783A (en) | 2021-12-24 |
Family
ID=53267232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ735783A NZ735783A (en) | 2015-05-21 | 2016-05-20 | Antifungal 4-(4-(4-(((3r,5r)-5-((1 h -1,2,4-triazol-1 -yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)- 3-methylphenyl)piperazin-1 -yl )-n -(2-h yd roxycyc lo h exyl) b e nzam i d e, or a pharmaceutically acceptable salt thereof. |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US9969720B2 (zh) |
| EP (1) | EP3298006B1 (zh) |
| JP (1) | JP6811727B2 (zh) |
| KR (1) | KR102653821B1 (zh) |
| CN (1) | CN107635988B (zh) |
| AU (1) | AU2016263669B2 (zh) |
| CA (1) | CA2981945C (zh) |
| DK (1) | DK3298006T3 (zh) |
| EA (1) | EA032454B1 (zh) |
| ES (1) | ES2790723T3 (zh) |
| HK (1) | HK1252779A1 (zh) |
| HU (1) | HUE048843T2 (zh) |
| IL (1) | IL254943B (zh) |
| MX (1) | MX2017014814A (zh) |
| NZ (1) | NZ735783A (zh) |
| SG (1) | SG11201708007VA (zh) |
| WO (1) | WO2016185225A1 (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102653821B1 (ko) * | 2015-05-21 | 2024-04-02 | 풀모사이드 리미티드 | 항진균성 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-트리아졸-1-일)메틸)-5-(2,4-디플루오로페닐)테트라하이드로푸란-3-일)메톡시)-3-메틸페닐)피페라진-1-일)-n-(2-하이드록시사이클로헥실)벤즈아미드 또는 이의 약학적으로 허용가능한 염. |
| CN109329288A (zh) * | 2018-11-09 | 2019-02-15 | 青岛农业大学 | 伏立康唑在制备用于防治植物病原菌的杀菌剂中的应用 |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1292472C (en) | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
| AU2811689A (en) | 1987-11-20 | 1989-06-14 | Schering Corporation | Tri-and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof |
| US5039676A (en) * | 1990-05-11 | 1991-08-13 | Schering Corporation | Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof |
| ES2159623T3 (es) * | 1993-12-21 | 2001-10-16 | Schering Corp | Antifungicos de tetrahidrofurano. |
| US5714490A (en) | 1993-12-21 | 1998-02-03 | Schering Corporation | Tetrahydrofuran antifungals |
| US5486625A (en) | 1994-07-08 | 1996-01-23 | Schering Corporation | Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents |
| CA2197672C (en) | 1995-06-02 | 2011-05-17 | Anil K. Saksena | Tetrahydrofuran antifungals |
| EP0957101A1 (en) * | 1998-05-14 | 1999-11-17 | Janssen Pharmaceutica N.V. | Water soluble azoles as broad-spectrum antifungals |
| HUP0400856A3 (en) | 2001-04-03 | 2012-09-28 | Merck Sharp & Dohme | Antifungal composition |
| EP1870405A1 (en) * | 2006-06-22 | 2007-12-26 | Bioprojet | Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands |
| CN101402613B (zh) * | 2008-11-14 | 2013-07-24 | 中国人民解放军第二军医大学 | 取代酚氧烷基胺三唑醇类抗真菌化合物及其制备方法 |
| CN102234267A (zh) * | 2010-04-21 | 2011-11-09 | 中国科学院上海药物研究所 | 新型三氮唑类抗真菌化合物、其药物组合物及其制备方法和用途 |
| WO2013036866A1 (en) * | 2011-09-07 | 2013-03-14 | The Johns Hopkins University | Itraconazole analogs and use thereof |
| EP3227277B1 (en) | 2014-12-05 | 2020-02-05 | Pulmocide Limited | Antimycotic compound |
| KR102653821B1 (ko) * | 2015-05-21 | 2024-04-02 | 풀모사이드 리미티드 | 항진균성 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-트리아졸-1-일)메틸)-5-(2,4-디플루오로페닐)테트라하이드로푸란-3-일)메톡시)-3-메틸페닐)피페라진-1-일)-n-(2-하이드록시사이클로헥실)벤즈아미드 또는 이의 약학적으로 허용가능한 염. |
-
2016
- 2016-05-20 KR KR1020177033395A patent/KR102653821B1/ko active IP Right Grant
- 2016-05-20 ES ES16724958T patent/ES2790723T3/es active Active
- 2016-05-20 AU AU2016263669A patent/AU2016263669B2/en active Active
- 2016-05-20 EP EP16724958.0A patent/EP3298006B1/en active Active
- 2016-05-20 CN CN201680028971.4A patent/CN107635988B/zh active Active
- 2016-05-20 WO PCT/GB2016/051467 patent/WO2016185225A1/en active Application Filing
- 2016-05-20 HU HUE16724958A patent/HUE048843T2/hu unknown
- 2016-05-20 NZ NZ735783A patent/NZ735783A/en unknown
- 2016-05-20 SG SG11201708007VA patent/SG11201708007VA/en unknown
- 2016-05-20 DK DK16724958.0T patent/DK3298006T3/da active
- 2016-05-20 JP JP2017560525A patent/JP6811727B2/ja active Active
- 2016-05-20 MX MX2017014814A patent/MX2017014814A/es unknown
- 2016-05-20 EA EA201792558A patent/EA032454B1/ru not_active IP Right Cessation
- 2016-05-20 CA CA2981945A patent/CA2981945C/en active Active
- 2016-11-09 US US15/347,402 patent/US9969720B2/en active Active
-
2017
- 2017-10-09 IL IL254943A patent/IL254943B/en active IP Right Grant
-
2018
- 2018-05-04 US US15/971,316 patent/US10280155B2/en active Active
- 2018-09-20 HK HK18112141.3A patent/HK1252779A1/zh unknown
-
2019
- 2019-03-20 US US16/359,349 patent/US10513511B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10513511B2 (en) | 2019-12-24 |
| US9969720B2 (en) | 2018-05-15 |
| EP3298006B1 (en) | 2020-01-01 |
| MX2017014814A (es) | 2018-02-15 |
| US10280155B2 (en) | 2019-05-07 |
| US20190202813A1 (en) | 2019-07-04 |
| IL254943A0 (en) | 2017-12-31 |
| IL254943B (en) | 2021-01-31 |
| EA032454B1 (ru) | 2019-05-31 |
| KR102653821B1 (ko) | 2024-04-02 |
| JP2018520104A (ja) | 2018-07-26 |
| AU2016263669A1 (en) | 2017-10-12 |
| US20180251453A1 (en) | 2018-09-06 |
| HK1252779A1 (zh) | 2019-05-31 |
| CA2981945A1 (en) | 2016-11-24 |
| BR112017020807A2 (pt) | 2018-07-03 |
| ES2790723T3 (es) | 2020-10-29 |
| DK3298006T3 (da) | 2020-03-30 |
| AU2016263669B2 (en) | 2020-04-30 |
| KR20180010189A (ko) | 2018-01-30 |
| HUE048843T2 (hu) | 2020-08-28 |
| US20170114047A1 (en) | 2017-04-27 |
| CN107635988B (zh) | 2021-06-18 |
| SG11201708007VA (en) | 2017-12-28 |
| CN107635988A (zh) | 2018-01-26 |
| CA2981945C (en) | 2023-08-29 |
| JP6811727B2 (ja) | 2021-01-20 |
| WO2016185225A1 (en) | 2016-11-24 |
| EP3298006A1 (en) | 2018-03-28 |
| EA201792558A1 (ru) | 2018-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018500284A1 (en) | 5-bromo-2,6-di-(1h-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer | |
| CY1123810T1 (el) | Τριφθορομεθυλ υποκατεστημενα πυραζολια ως αναστολεις καλλικρεϊνης στο ανθρωπινο πλασμα | |
| PH12017500276A1 (en) | Aminopyrimidinyl compounds as jak inhibitors | |
| MY196243A (en) | Dihydropyrimidine Compounds and Their Application In Pharmaceuticals | |
| MY195427A (en) | Jak Kinase Inhibitor Compounds for Treatment of Respiratory Disease | |
| TN2016000268A1 (en) | N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of shp2. | |
| MX2016012574A (es) | Compuestos heteroarilo sustituidos y metodos de uso. | |
| MY192521A (en) | Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors | |
| CL2015000578A1 (es) | Compuesto n-(2-(6-fluoro-1-h-indol-3-il)etil)-3-(2,2,3,3-tetrafluoropropoxi)bencilamina o su sal, antagonista del receptor 5-ht6; composicion farmaceutica; uso en el tratamiento de la enfermedad de alzheimer. | |
| CL2016001918A1 (es) | Heteroaril amidas como inhibidores de agregación de proteína | |
| MX2017006447A (es) | Agentes antifungicos. | |
| NZ725399A (en) | Macrocylic pyrimidine derivatives | |
| PH12016502394A1 (en) | 1, 3, 4-thiadiazole compounds and their use in treating cancer | |
| PH12018500377A1 (en) | Novel annelated benzamides | |
| PH12018500378B1 (en) | Novel annelated phenoxyacetamides | |
| ZA201804843B (en) | Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl) acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1h-1,2,3-triazole-4-carboxamide | |
| WO2016198698A8 (en) | P38 inhibitors for the treatment and prophylaxis of liver cancer | |
| NZ735783A (en) | Antifungal 4-(4-(4-(((3r,5r)-5-((1 h -1,2,4-triazol-1 -yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)- 3-methylphenyl)piperazin-1 -yl )-n -(2-h yd roxycyc lo h exyl) b e nzam i d e, or a pharmaceutically acceptable salt thereof. | |
| PH12016501625A1 (en) | Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists | |
| PH12017501668A1 (en) | Bace1 inhibitors | |
| PH12017501955A1 (en) | Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer`s disease | |
| EP3807254A4 (en) | HETEROCYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DISEASE | |
| EA201792265A1 (ru) | Способы лечения сердечно-сосудистых заболеваний | |
| TH167963B (th) | อนุพันธ์ไพริดีนชนิดมาโครไซคลิก |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 MAY 2023 BY CAMILLA WELLIN / CPA GLOBAL CLARIVATE Effective date: 20220507 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 MAY 2024 BY CPA GLOBAL (PATRAFEE) AB Effective date: 20230504 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 20 MAY 2025 BY CPA GLOBAL (PATRAFEE) AB Effective date: 20240425 |